ILOODA CO., LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,220 KRW | -1.27% |
|
-2.35% | -8.66% |
| 2023 | CLASSYS Inc. agreed to acquire 17.999971% stake in Ilooda Co., Ltd from Kim Yong Han for KRW 40.5 billion. | CI |
| 2023 | Bain Capital May Acquire Ilooda for $158m | CI |
| Sales 2022 | 46.28B 33.65M | Sales 2023 | 56.2B 40.86M | Capitalization | 139B 101M |
|---|---|---|---|---|---|
| Net income 2022 | 7.88B 5.73M | Net income 2023 | -4.3B -3.13M | EV / Sales 2022 | 2.74 x |
| Net Debt 2022 | 16.19B 11.77M | Net Debt 2023 | 7.34B 5.34M | EV / Sales 2023 | 2.6 x |
| P/E ratio 2022 |
15.3
x | P/E ratio 2023 |
-30.9
x | Employees | 112 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 62.05% |
More Fundamentals
* Assessed data
More news
| 1 day | -1.27% | ||
| 1 week | -2.35% | ||
| Current month | -0.64% | ||
| 1 month | -1.74% | ||
| 3 months | -12.27% | ||
| 6 months | -11.77% | ||
| Current year | -8.66% |
1 week
6 190.00
6 640.00
1 month
5 960.006 700.00
Current year
5 800.007 820.00
1 year
5 800.0011 530.00
3 years
4 250.0011 530.00
5 years
4 250.0011 530.00
10 years
4 250.0011 530.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yong-Han Kim
CEO | Chief Executive Officer | 49 | - |
Hyo-Jae Moon
CTO | Chief Tech/Sci/R&D Officer | 55 | 14-12-31 |
Seung-Yong Park
AUD | Comptroller/Controller/Auditor | 43 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yong-Han Kim
CEO | Chief Executive Officer | 49 | - |
Young-Soo Seol
BRD | Director/Board Member | 55 | 12-12-31 |
Yong-Hyun Yoon
BRD | Director/Board Member | 52 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 6,220 | -1.27% | 90,272 |
| 24-04-25 | 6,300 | -2.33% | 114,649 |
| 24-04-24 | 6,450 | +0.16% | 94,380 |
| 24-04-23 | 6,440 | -0.46% | 143,885 |
| 24-04-22 | 6,470 | +1.57% | 172,494 |
End-of-day quote Korea S.E., April 25, 2024
More quotes
Ilooda Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medical devices. The Company's main products include medical devices for skin care, medical devices for pigmentation and blood vessels, home and personal beauty devices, dental medical devices, ophthalmic medical devices, and other medical devices. The Company sells its products in domestic and overseas markets.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.66% | 92.12M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- A164060 Stock
